Akero Therapeutics (AKRO) Slides After Failed Trial, Hit With Class Action Lawsuit – Hagens Berman
GlobeNewswire
SAN FRANCISCO, May 02, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Akero Therapeutics, Inc. *(NASDAQ: AKRO)* investors who..
SAN FRANCISCO, May 02, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Akero Therapeutics, Inc. *(NASDAQ: AKRO)* investors who..
The rate of businesses in the U.S. using AI is still relatively small but growing rapidly. A new paper by U.S. Census Bureau..
RALEIGH, N.C., May 02, 2024 (GLOBE NEWSWIRE) -- In a special presentation, the Board of Directors of State Employees’ Credit..